Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Vaccine. 2020 Apr 11;38(22):3854–3861. doi: 10.1016/j.vaccine.2020.03.044

Table 4.

Exploratory factor analysis for the brief measure of Ebola vaccine demand among respondents# in a national household survey, Sierra Leone, December 2014.

Item Range Mean SD* Loadings Uniqueness
“A vaccine to protect against Ebola is needed to help fight Ebola in Sierra Leone. 1–3 2.90 0.37 0.57 0.67
If a vaccine that has been tested to be safe in humans and could protect against Ebola becomes available in Sierra Leone, how likely would you be to take it? 1–4 3.72 0.59 0.95 0.09
If a vaccine that has been tested to be safe in humans and could protect against Ebola becomes available in Sierra Leone, how likely would your family be to take it? 1–4 3.70 0.61 0.95 0.10
#

N = 3540 respondents.

*

SD = standard deviation.